949159-95-9

Basic information

• Product Name: Ethanone, 1-(4-fluoro-3-hydroxyphenyl)-
• Synonyms: Ethanone, 1-(4-fluoro-3-hydroxyphenyl)-;1-(4-Fluoro-3-hydroxyphenyl)ethanone
• CAS NO: 949159-95-9
• Molecular Formula: C₈H₇FO₂
• Molecular Weight: 154.14
• Mol File: 949159-95-9.mol
• Article Data: 5

Chemical Properties

• Melting Point: 119-126℃
• Appearance: /
• Storage Temp.: 2-8°C
• Solubility: Slightly Soluble (1.1 g/L) (25°C).
• CAS DataBase Reference: Ethanone, 1-(4-fluoro-3-hydroxyphenyl)-(CAS DataBase Reference)
• NIST Chemistry Reference: Ethanone, 1-(4-fluoro-3-hydroxyphenyl)-(949159-95-9)
• EPA Substance Registry System: Ethanone, 1-(4-fluoro-3-hydroxyphenyl)-(949159-95-9)

Safety Data

• Hazardous Substances Data: 949159-95-9(Hazardous Substances Data)

Usage

Uses

Participate in the preparation of 4-fluoro-2-nitrobenzonitrile(an intermediate).

Upstream product

• 937079-77-1 1-(3-(pyridin-2-yloxy)phenyl)ethanone 
• 121-71-1 3-Hydroxyacetophenone 
• 64287-19-0 1-(4-fluoro-3-methoxy-phenyl)ethanone 
• 2002-82-6 1-(3-amino-4-fluorophenyl)ethanone 
• 369-33-5 3',4'-difluoroacetophenone 

Downstream Products

• 64287-19-0 1-(4-fluoro-3-methoxy-phenyl)ethanone 
• 1072710-27-0 4'-fluoro-3'-hydroxyacetophenone-O-[(benzo[c][1,2,5]oxadiazol-5-yl)methyl]oxime 
• 147379-67-7 methyl (4-fluoro-3-phenoxyphenyl)-ketone 

Relevant articles and documents

Photohydration of benzophenone in aqueous acid

Why is the triplet state of aromatic ketones quenched by protons? The long-known but unexplained quenching process was investigated in detail for benzophenone (1). Adiabatic protonation of triplet benzophenone, 31, encounters a state symmetry-i

ARYLAMIDE DERIVATIVES AS TTX-S BLOCKERS

The present invention relates to arylamide derivatives which have blocking activities of voltage gated sodium channels as the TTX-S channels, and which are useful in the treatment or prevention of disorders and diseases in which voltage gated sodium channels are involved. The invention also relates to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which voltage gated sodium channels are involved.

PHOSPHODIESTERASE 10 INHIBITORS

The present invention if directed to certain cinnoline compounds that are PDE10 inhibitors, pharmaceutical compositions containing such compounds and processes for preparing such compounds. The invention is also directed to methods of treating diseases mediated by PDE10 enzyme, such as obesity, non-insulin dependent diabetes, schizophrenia, bipolar disorder, obsessive-compulsive disorder, and the like.